Navigation Links
How DDT metabolite disrupts breast cancer cells
Date:2/13/2008

Research has shown that the main metabolite of the insecticide DDT could be associated with aggressive breast cancer tumours, but there has been no explanation for this observation to date. Now a report published in the open access journal Breast Cancer Research shows how DDT could act to disrupt hormone-sensitive breast cancer cells.

Michel Aube and colleagues from Universite Laval and Institut national de sante publique in Quebec, Canada have published findings suggesting that DDT's main metabolite, 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,pi'-DDE), could increase breast cancer progression. They suggest a mechanism whereby p,p'-DDE opposes the androgen signalling pathway that inhibits growth in hormone-responsive breast cancer cells.

The team tested the effect of p,p'-DDE on the proliferation of CAMA-1 cells, a human breast cancer cell line that expresses the estrogen receptor alpha (ERa) and the androgen receptor (AR), either with or without physiological concentrations of estrogens and androgens. They also assessed p,p'-DDE-induced modifications in cell cycle entry and the expression of sex-steroid dependent genes including ESR1 and CCND1, the latter coding for a key protein involved in cell proliferation.

When estrogens and androgens were present in the cell culture medium, increasing concentrations of p,p'-DDE accelerated the growth of CAMA-1 breast cancer cells. p,p'-DDE had a similar effect on the proliferation of MCF7-AR1 cells, an estrogen responsive cell line genetically engineered to over express the AR. Adding the potent androgen dihydrotestosterone together with estradiol to the cell culture medium decreased the recruitment of CAMA-1 cells in the S phase and the expression of ESR1 and CCND1, by comparison with cells treated with estradiol alone. These androgen-mediated effects were blocked with similar efficacy by p,p'-DDE and the potent antiandrogen hydroxyflutamide.

'Our results suggest that in additi
'/>"/>

Contact: Charlotte Webber
press@biomedcentral.com
44-020-763-19980
BioMed Central
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Nicotine in breast milk disrupts infants sleep patterns
2. Antibacterial chemical disrupts hormone activities
3. Survival differences by race most apparent in advanced stages of breast cancer
4. MRI finds breast cancer before it becomes dangerous
5. Pathway links inflammation, angiogenesis and breast cancer
6. Drop in breast cancer incidence linked to hormone use, not mammograms
7. Breast cancer prevention practices vary across Canada
8. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
9. Acrylamide Wont Raise Breast Cancer Risk
10. New link between estrogen and breast cancer
11. Hypnosis Eases Pain of Breast Cancer Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2015)... FL (PRWEB) May 02, 2015 We ... selected The Delray Recovery Center as one of the ... is known in the addiction treatment field for their ... members to innovate and to continue their educational efforts. ... positive workplace environment, never forgetting their purpose – to ...
(Date:5/2/2015)... Kare Visits LLC. launched in Chicago in response ... Kare Visits offers relief for caregivers by visiting loved ones ... According to the Caregiver Action Network, eight in ten caregivers ... a week caring for an elderly or disabled loved one. ... nurse, a caregiver is now empowered to schedule an on ...
(Date:5/2/2015)... With the success that Veatch Dental Consulting ... welcome Neida Miranda and Alex Shields to the team. With ... 41 years of combined experience working with dentists to ensure ... field for 8 years. She was certified as dental ... service, positive attitude and showing the importance of oral hygiene ...
(Date:5/1/2015)... NY (PRWEB) May 01, 2015 Pioneer ... will share the latest in their reclaimed wood products ... at the Jacob Javits Center in NYC this May. ... Boards, will bring much anticipated texture and color to ... seen an explosion of texture and color in the ...
(Date:5/1/2015)... The Workgroup for Electronic Data ... the use of health IT to create efficiencies in ... to the United States Government Accountability Office (GAO) for ... in Medicare. The report, “ Potential Uses of Electronically ... to the public on Apr. 24, 2015 and examines ...
Breaking Medicine News(10 mins):Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3
... LIMA, Peru, Jan. 14 The National Cancer ... to announce a pilot program to assist cancer ... cancer-related medicines Mylotarg(TM) (gemtuzumab ozogamicin for injection) and ... the Peruvian Health Ministry participated in a hand-over ...
... Also Provides Additional Patient Advocacy Protections for Texas NursesAUSTIN, ... direct patient care in Texas hospitals will gain even ... to 2009 legislation filed today. The legislation, authored in ... in the House by Rep. Donna Howard (D-Austin), and ...
... Columbus, OH January 14, 2009 Obesity continues ... among African-American and Mexican-American women. Between the ages of ... million African-American women, and 575,000 Mexican-American women who are ... Public Health Nursing reveals that there is an ...
... On the heels of a successful,launch of its ... Insurance Company today announced that Community Flex(TM) is now,available ... consumer,s hold,down their medical expenses, the new PPO plan ... a coverage effective date beginning,March 1, 2009. , ...
... affected by chronic inflammation without knowing much about it. FlameEz.com is ... inflammation, the root cause of many of the most feared illnesses ... ... PA (PRWEB) January 14, 2009 -- Millions of Americans are affected ...
... -- China-Biotics, Inc.,(Nasdaq: CHBT ) ... in the manufacture, research, development, marketing and,distribution ... signed contracts,with four food manufacturers -- Shanghai ... Dairy Industry Co., Ltd. ("Huwa Dairy"), Qinghai ...
Cached Medicine News:Health News:NCC and Wyeth Donation to Assist Cancer Patients in Latin America 2Health News:Legislation Would Give Texas Nurses Even Stronger Voice in Hospital Staffing 2Health News:Legislation Would Give Texas Nurses Even Stronger Voice in Hospital Staffing 3Health News:Economic status affects obesity rates in Mexican-American and white women 2Health News:American Community Introduces Community Flex(TM), an Affordable Health Plan in Arizona and Indiana 2Health News:Control of Inflammation May Benefit Many of the Most Feared Illnesses in Middle and Old Age 2Health News:Control of Inflammation May Benefit Many of the Most Feared Illnesses in Middle and Old Age 3Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 2Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 3Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 4
(Date:4/30/2015)... Abaxis, Inc. (NasdaqGS: ABAX ), a medical products ... results for the fourth quarter and fiscal year ended ... 2015 overview: , Revenues from continuing operations of ... last year,s comparable quarter, and $202.6 million for fiscal ... $0.50 for the fourth quarter, up 194% over last ...
(Date:4/30/2015)...  Thoratec Corporation (NASDAQ: THOR ), a world ... and restore failing hearts, said today it will participate ... Conference on Thursday, May 14. D. ... provide an update on the company, beginning at 10:40 ... The presentation will be available through the ...
(Date:4/30/2015)... Maine , April 30, 2015 Pharmacists at ... 340 in South Portland, Maine . The ... Osco pharmacies located within 16 Shaw,s supermarkets throughout ... work with the Osco pharmacists in securing them the powerful ... said Brett Miller , President of Local 340. "We ...
Breaking Medicine Technology:Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 2Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 3Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 4Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 5Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 6Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 7Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 8Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 9Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 10Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 11Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 12Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 13Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 14Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 15Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 16Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 17Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 18Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 19Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 20Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 21Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 22Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 23Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 24Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast 2
... YORK, Oct. 27 ACCESS PHARMACEUTICALS, INC. ... a biopharmaceutical company leveraging its proprietary drug-delivery platforms ... care and diabetes, announced it has entered ... company to develop an oral formulation of an undisclosed ...
... Calif., Oct. 26 Varian Medical Systems (NYSE: ... investor event on Tuesday, November 2 at the annual ... Oncology (ASTRO) in San Diego.  The meeting and presentation ...  To access the webcast, click on http://investors.varian.com/index.php?s=19&item=148 . ...
Cached Medicine Technology:Access Pharmaceuticals Signs Agreement With Leading Biopharmaceutical Company to Develop CobOral™ Formulation of Widely-Marketed Injectable 2Access Pharmaceuticals Signs Agreement With Leading Biopharmaceutical Company to Develop CobOral™ Formulation of Widely-Marketed Injectable 3Varian Medical Systems Schedules Webcast of Investor Meeting and Fiscal Year End Review at ASTRO in San Diego, November 2, 2010 2
... Lawson Lite positions directly over one,eye ... the lens an exclusive feature ... fiber optic light that penetrates,deep into ... universal swivel mount enables the,surgeon to ...
The Convertible lets you attach the,High Lite optic directly to your loupes....
Mounted on a sturdy, molded headband,the Classic has a fully adjustable,crown strap and cushioning that adds,to your comfort....
Mounted on a sturdy, molded headband,the Classic has a fully adjustable crown,strap and cushioning that adds to,your comfort....
Medicine Products: